These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11095886)

  • 1. Increasing Antimicrobial Resistance: Therapeutic Implications for Enterococcal Infections.
    Levison ME; Mallela S
    Curr Infect Dis Rep; 2000 Oct; 2(5):417-423. PubMed ID: 11095886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment options for vancomycin-resistant enterococcal infections.
    Linden PK
    Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing therapy for vancomycin-resistant enterococci (VRE).
    Linden PK
    Semin Respir Crit Care Med; 2007 Dec; 28(6):632-45. PubMed ID: 18095227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoglycoside resistant enterococcal endocarditis.
    Eliopoulos GM
    Infect Dis Clin North Am; 1993 Mar; 7(1):117-33. PubMed ID: 8463648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enterococci: susceptibility patterns and therapeutic options.
    Nicoletti G; Stefani S
    Eur J Clin Microbiol Infect Dis; 1995; 14 Suppl 1():S33-7. PubMed ID: 7729470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enterococcal bacteremia: clinical features, the risk of endocarditis, and management.
    Maki DG; Agger WA
    Medicine (Baltimore); 1988 Jul; 67(4):248-69. PubMed ID: 3134590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis and treatment of enterococcal infections.
    Gross MH; Barriere SL
    Clin Pharm; 1984; 3(2):161-6. PubMed ID: 6373101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combatting resistant enterococcal infections: a pharmacotherapy review.
    Mercuro NJ; Davis SL; Zervos MJ; Herc ES
    Expert Opin Pharmacother; 2018 Jun; 19(9):979-992. PubMed ID: 29877755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combination therapy against vancomycin-resistant enterococci].
    Kariyama R; Kumon H
    Nihon Rinsho; 2001 Apr; 59(4):733-8. PubMed ID: 11304998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of quinupristin/dalfopristin against gram-positive bacteria: clinical applications and therapeutic potential.
    Rubinstein E; Bompart F
    J Antimicrob Chemother; 1997 May; 39 Suppl A():139-43. PubMed ID: 9511078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].
    Rudy M; Nowakowska M; WiechuĊ‚a B; Zientara M; Radosz-Komoniewska H
    Przegl Lek; 2004; 61(5):473-6. PubMed ID: 15515808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic and genotypic study of biofilm formation in Enterococci isolated from urinary tract infections.
    Fallah F; Yousefi M; Pourmand MR; Hashemi A; Nazari Alam A; Afshar D
    Microb Pathog; 2017 Jul; 108():85-90. PubMed ID: 28483600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High incidence of virulence determinants, aminoglycoside and vancomycin resistance in enterococci isolated from hospitalized patients in Northwest Iran.
    Haghi F; Lohrasbi V; Zeighami H
    BMC Infect Dis; 2019 Aug; 19(1):744. PubMed ID: 31455296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approaches to vancomycin-resistant enterococci.
    Torres-Viera C; Dembry LM
    Curr Opin Infect Dis; 2004 Dec; 17(6):541-7. PubMed ID: 15640708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Species distribution and antibiotic resistance patterns of enterococci isolated from food of animal origin in Germany.
    Peters J; Mac K; Wichmann-Schauer H; Klein G; Ellerbroek L
    Int J Food Microbiol; 2003 Dec; 88(2-3):311-4. PubMed ID: 14597003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management.
    O'Driscoll T; Crank CW
    Infect Drug Resist; 2015; 8():217-30. PubMed ID: 26244026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features of enterococcal bacteremia due to ampicillin-susceptible and ampicillin-resistant enterococci: An eight-year retrospective comparison study.
    Hamada Y; Magarifuchi H; Oho M; Kusaba K; Nagasawa Z; Fukuoka M; Yamakuchi H; Urakami T; Aoki Y
    J Infect Chemother; 2015 Jul; 21(7):527-30. PubMed ID: 25935477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical manifestations of enterococcal infection.
    Lewis CM; Zervos MJ
    Eur J Clin Microbiol Infect Dis; 1990 Feb; 9(2):111-7. PubMed ID: 2180706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic impact of streptococcal and enterococcal bacteremia in hematology patients].
    Ombandza-Moussa E; Schlegel L; Vekhoff A; Gerbal R; Marie JP; Bouvet A
    Pathol Biol (Paris); 2002 Apr; 50(3):169-77. PubMed ID: 11980330
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.